Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Start the video

Stefan Oschmann, CEO Pharma, in a video-interview

Our biopharmaceutical businesses are well on track. This is reflected for example by the successful execution of growth initiatives and by progress in the pipeline. This progress can be seen particularly in Immuno-Oncology, among others. Additionally Merck KGaA, Darmstadt, Germany, plans to step up investments in its Biosimilars unit next year.

Investor & Analyst Day on Biopharma 2014

This site provides a wealth of information on progress made and the strategic outlook for our biopharmaceutical businesses.


Press Kit
The zip file contains presentations, photos and more information.


Presentation held by management at the press conference.


Gangolf Schrimpf
Gangolf Schrimpf
Tel: +49 6151 72 9591
Fax: +49 6151 72-919591


Press Conference
You will find a recording of the journalist conference call here.


Analyst Webcast
You will find a recording of the analyst webcast here.

Related videos


Marcus Kuhnert
CFO Marcus Kuhnert in a video interview.


Belén Garijo
Belén Garijo, CEO of our biopharma business, in a video interview.


Luciano Rossetti
Luciano Rossetti, Head of R&D at our biopharma business, in a video interview.


Publication of Merck KGaA, Darmstadt, Germany.
There are two different, unaffiliated companies that use the name MERCK. Merck KGaA, Darmstadt, Germany, which operates this website, uses the firm name “Merck KGaA, Darmstadt, Germany,” in the United States and Canada, and also uses “EMD Serono” in biopharma, “MilliporeSigma” in life science and “EMD Performance Materials” in materials business. The other company, Merck & Co., Inc. holds the rights in the trademark MERCK in the United States and Canada. Merck & Co. is not affiliated with or related to Merck KGaA, Darmstadt, Germany, which owns the MERCK trademark in all other countries of the world.   To reflect such fact and to avoid any confusion, certain logos, terms and business descriptions of the publications on this website have been substituted or modified, such as by referring to “Merck KGaA, Darmstadt, Germany” instead of “Merck” standing alone.  Publications on this webpage, therefore, slightly deviate from the otherwise identical versions accessible outside the United States and Canada.